Changes to the EMA’s registration process for SMEs

pharmafile | November 22, 2011 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates 

The European Medicines Agency (EMA) has recently made changes to its process for the registration of micro, small or medium-sized enterprises (SMEs) which are expected to reduce the administrative burden on companies and to speed up the SME assignment and renewal process.  The financial incentives and support available to registered companies are significant and companies should be encouraged to consider their eligibility from the outset in any European regulatory strategy. 

Wainwright Associates are experts in assisting eligible companies achieve SME status and supporting them throughout all phases of product development, regulatory affairs, pharmacovigilance and licensing.  To discuss your requirements, contact us at enquiries@wainwrightassociates.co.uk or call +44 (0)1628 530554.

Related Content

Submission of labels and leaflets in the UK

The MHRA has announced procedural changes concerning the requirement to submit full-colour mock-ups of labels …

On-going Medicine evaluation Information to be published by European Medicines Agency

Following the recommendations on transparency published by the European Heads of Medicines Agencies (HMA) and …

MHRA Inspections of CROs

In accordance with the provisions of the new pharmacovigilance legislation, as per Directive 2010/84/EU, EU …

The Gateway to Local Adoption Series

Latest content